Allows single antibody molecule to bind to an antigen multiple times while conventional antibody can only bind to the antigen once. Applied to FDA-approved product, satralizumab.
The Sweeping Antibody® is a recycling antibody that has been further engineered to bind to FcRn at neutral pH.
A bispecific antibody can bind to two different antigens with the two arms of antibody.
T-Cell Redirecting Antibody
TRAB antibodies target against various tumor antigens.
Switch-Ig® is an antibody that specifically binds to the target antigen in the tumor microenvironment.